Report Detail
Respiratory Care Devices Global Market - Forecast to 2026
- RnM3925067 |
- 12 March, 2020 |
- Global |
- 688 Pages |
- IQ4I Research & Consultancy |
- Medical Devices & Consumables
Respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), sleep apnea and others are increasing due to tobacco smoking, second-hand smoking, vehicular smoke emissions, urbanization, industrializations and changing lifestyle. To control these conditions the usage of respiratory devices are rising. The Respiratory care device is one of the parts of medical device which is used for diagnosis, treatment and monitoring purpose. The respiratory care device global market is segmented based on the products, applications, end-users, and geography. Globally respiratory care devices market is showing rapid growth and also in coming years continuing to evolve in the field of research, development, and manufacturing due to its wide range of driving factors such as the increase in the incidence of respiratory diseases, rising use of non-invasive respiratory care devices and growing demand for homecare respiratory devices.
According to IQ4I analysis, the respiratory care devices global market is expected to grow at high single digit CAGR from 2019 to 2026 to reach $23,510.9 million by 2026. Respiratory care devices products market is segmented as diagnostic, therapeutic, monitoring devices, and consumables. The therapeutic devices market commanded the largest share in 2019, and the market is expected to grow at a strong single digit CAGR from 2019 to 2026.
The therapeutic devices product market is segmented into humidifiers, nebulizers, oxygen concentrators, PAP devices, resuscitators, ventilators, inhalers and others. According to IQ4I analysis, among therapeutic devices segment, ventilators commanded the largest revenue in 2019, the market is expected to grow at a mid single digit CAGR from 2019 to 2026. The PAP devices are expected to grow at a strong double digit CAGR from 2019 to 2026. The monitoring devices market is expected to grow at a mid single digit CAGR from 2019 to 2026. The monitoring devices are segmented into pulse oximeter, capnographs and gas analyzers. The pulse oximeters commanded the largest revenue in 2019 and the capnographs are expected to grow at a strong single digit CAGR from 2019 to 2026. The diagnostic devices are expected to grow at a mid single digit CAGR from 2019 to 2026. The diagnostic devices are segmented into spirometers, peak flow meters and polysomnographs, among these, spirometers commanded the largest share in 2019, peak flow meters are expected to grow at a single digit CAGR from 2019 to 2026. The consumables market is expected to grow at a single digit CAGR from 2019 to 2026. The consumables are segmented based on product into masks, nasal cannula, treachostomy devices and others. Mask commanded the largest revenue is expected to grow at a high single digit CAGR from 2019 to 2026.
The respiratory care devices market based on application is segmented into obstructive, restrictive, vascular, infectious and other respiratory conditions. Among applications, obstructive respiratory conditions commanded the largest revenue in 2019. The market is expected to grow at a high single digit CAGR from 2019 to 2026. The obstructive respiratory conditions are further segmented into COPD (chronic broinchitis and emphysema), asthma, cystic fibrosis, and obstructive sleep apnea, the COPD commanded the largest share of the market in 2019 and is expected to grow at a high single digit CAGR from 2019 to 2026.
The end-users market is segmented into hospitals, home care and ambulatory surgical centers, among them, hospital care settings commanded the largest revenue in 2019. Globally, admission to emergency care is increasing due to respiratory disorder burdens and majorly respiratory therapists are treating more number of patients in these care settings. The Homecare setting is expected to grow at a strong single digit CAGR from 2019 to 2026. Respiratory home healthcare has opened new opportunities for the respiratory care devices market. The convenient and comfort at homecare environment, cost of the devices, rental respiratory devices, oxygen resupply systems and other factors shifting the hospital care environment to homecare environment. The hospital end-user segment is further sub-segmented based on care settings into emergency care, critical care/ICU, acute care, sleep center and others. The critical care segment commanded the largest revenue in 2019. The sleep centers are expected to grow at strong single digit CAGR from 2019 to 2026.
The geographic market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Among these, North-America commanded the largest revenue in 2019. The market is expected to grow at a high single digit CAGR from 2019 to 2026 due to advancements in technology, demand for a respiratory disorder, healthcare expenditures by government reforms, and availability of skilled labors. Asia-Pacific is expected to grow at a strong double digit CAGR from 2019 to 2026. Asia-Pacific tends to be fastest-growing segment due to increase in investments in the healthcare sector and emerging economies which creates new opportunities. The other factors influencing are incorporating new technologies, growing health awareness, expansion in healthcare industry, fast economic growth, increasing aging populations, High prevalence of tobacco smoking, Increasing medical expenditure, and health awareness improvements.
1 EXECUTIVE SUMMARY 37
2 INTRODUCTION 42
- 2.1 KEY TAKEAWAYS 42
- 2.2 REPORT SCOPE 43
- 2.3 REPORT DESCRIPTION 43
- 2.4 MARKETS COVERED 45
- 2.5 STAKEHOLDERS 48
- 2.6 RESEARCH METHODOLOGY 49
- 2.6.1 MARKET SIZE ESTIMATION 51
- 2.6.2 MARKET CRACKDOWN AND DATATRIANGULATION 53
- 2.6.3 SECONDARY SOURCES 54
- 2.6.4 PRIMARY SOURCES 54
- 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 55
- 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 55
- 2.6.7 ASSUMPTIONS 56
3 MARKET OVERVIEW 57
- 3.1 INTRODUCTION 57
- 3.2 MARKET SEGMENTATION 58
- 3.3 FACTORS INFLUENCING MARKET 60
- 3.4 MARKET DYNAMICS 61
- 3.4.1 DRIVERS AND OPPORTUNITIES 61
- 3.4.1.1 Rising incidences of respiratory diseases due to urbanization and air pollution 61
- 3.4.1.2 Increasing tobacco usage 62
- 3.4.1.3 Rising use of non-invasive respiratory care devices 63
- 3.4.1.4 Growing demand for home care respiratory devices 64
- 3.4.1.5 Advancements of technology 65
- 3.4.1.6 A huge pool of undiagnosed patients 67
- 3.4.1.7 Favorable reimbursement scenario 68
- 3.4.2 RESTRAINTS AND THREATS 69
- 3.4.2.1 Product recalls 69
- 3.4.2.2 Harmful effects of certain devices on neonates 70
- 3.4.2.3 Availability of low-cost products from local manufacturers 71
- 3.4.2.4 Stringent regulatory policies 71
- 3.4.2.5 Lack of awareness of the disease 72
- 3.4.1 DRIVERS AND OPPORTUNITIES 61
- 3.5 REGULATORY AFFAIRS 73
- 3.5.1 U.S. 74
- 3.5.2 EUROPE 75
- 3.5.3 INDIA 77
- 3.5.4 CHINA 78
- 3.5.5 JAPAN 79
- 3.5.6 ISO STANDARDS 80
- 3.6 PORTER’S FIVE FORCE ANALYSIS 87
- 3.6.1 THREAT OF NEW ENTRANTS 87
- 3.6.2 THREAT OF SUBSTITUTES 88
- 3.6.3 COMPETITIVE RIVALRY 89
- 3.6.4 BARGAINING POWER OF SUPPLIERS 90
- 3.6.5 BARGAINING POWER OF BUYERS 90
- 3.7 MARKET SHARE ANALYSIS 92
- 3.7.1 RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE 92
- 3.7.2 VENTILATOR GLOBAL MARKET SHARE ANALYSIS 96
- 3.7.3 PAP GLOBAL MARKET SHARE ANALYSIS 98
- 3.7.4 CPAP GLOBAL MARKET SHARE ANALYSIS 100
- 3.7.5 APAP GLOBAL MARKET SHARE ANALYSIS 102
- 3.7.6 BPAP GLOBAL MARKET SHARE ANALYSIS 104
- 3.8 OTHER SUPPORTIVE RESPIRATORY DEVICES 105
- 3.8.1 SNORING DEVICE 105
- 3.8.2 NEUROMODULATION-BREATHING DISORDER
(OBSTRUCTIVE SLEEP APNEA) 106
- 3.9 REIMBURSEMENT SCENARIO 106
- 3.10 TECHNOLOGICAL ADVANCEMENTS 114
- 3.10.1 INTEGRATED DEVICES 114
- 3.10.2 REMOTE MONITORING 114
- 3.10.3 MOBILE OXYGEN CONCENTRATOR 115
- 3.10.4 MINIATURIZATION 115
- 3.10.5 WIRELESS TECHNOLOGY 115
- 3.10.6 WEARABLE TECHNOLOGY 116
- 3.10.7 HYPERSONIC NEBULIZER 116
- 3.10.8 DIGITAL TECHNOLOGIES IN RESPIRATORY DEVICES 116
- 3.11 UPCOMING TECHNOLOGY 117
- 3.12 FUNDING SCENARIO 118
- 3.13 RESPIRATORY CARE DEVICES - DEALS 120
- 3.14 PRODUCT LAUNCH, APPROVALS AND PATENT GRANTS 123
- 3.15 CLINICAL TRIALS 125
- 3.16 SUPPLY CHAIN ANALYSIS 127
4 RESPIRATORY CARE DEVICES GLOBAL MARKET, BY PRODUCTS 131
- 4.1 INTRODUCTION 131
- 4.2 THERAPEUTIC RESPIRATORY CARE DEVICES 134
- 4.2.1 HUMIDIFIERS 138
- 4.2.1.1 Active Humidifiers 142
- 4.2.1.2 Passive Humidifiers 145
- 4.2.2 NEBULIZERS 147
- 4.2.2.1 Jet Nebulizer 153
- 4.2.2.2 Ultrasonic Nebulizer 156
- 4.2.2.3 Mesh Nebulizer 159
- 4.2.2.4 Smart Nebulizer 162
- 4.2.3 OXYGEN CONCENTRATORS 163
- 4.2.3.1 Stationary Oxygen Concentrators 167
- 4.2.3.2 Portable Oxygen Concentrators 169
- 4.2.4 POSITIVE AIRWAY PRESSURE DEVICES (PAP) 171
- 4.2.4.1 Continuous PAP Devices (CPAP) 175
- 4.2.4.2 Automatic PAP (APAP) Devices 178
- 4.2.4.3 Bi-Level PAP (BPAP) Devices 181
- 4.2.5 RESUSCITATORS 184
- 4.2.5.1 Manual Resuscitator 188
- 4.2.5.2 Gas Powered Resuscitator 190
- 4.2.6 VENTILATORS 193
- 4.2.6.1 Non-Invasive Ventilators 197
- 4.2.6.2 Invasive Ventilators 199
- 4.2.7 VENTILATOR MARKET BY END-USERS 201
- 4.2.8 INHALERS 208
- 4.2.8.1 Dry Powder Inhalers 213
- 4.2.8.2 Metered Dose Inhaler 216
- 4.2.8.3 Soft Mist Inhaler 219
- 4.2.9 OTHERS 221
- 4.2.1 HUMIDIFIERS 138
- 4.3 MONITORING RESPIRATORY CARE DEVICES 223
- 4.3.1 PULSE OXIMETERS 227
- 4.3.1.1 Finger Pulse Oximeters 230
- 4.3.1.2 Handheld Pulse Oximeters 232
- 4.3.1.3 Wrist Pulse Oximeters 234
- 4.3.1.4 Tabletop Pulse Oximeters 237
- 4.3.2 CAPNOGRAPHS 239
- 4.3.3 GAS ANALYZERS 241
- 4.3.1 PULSE OXIMETERS 227
- 4.4 DIAGNOSTIC RESPIRATORY CARE DEVICES 244
- 4.4.1 SPIROMETERS 248
- 4.4.1.1 Volumetric Spirometers 253
- 4.4.1.2 Flow Measuring Spirometers 255
- 4.4.2 PEAK FLOW METERS 257
- 4.4.3 POLYSOMNOGRAPH DEVICES (PSG) 260
- 4.4.3.1 Clinical Polysomnography Devices 264
- 4.4.3.2 Ambulatory Polysomnography Devices 266
- 4.4.1 SPIROMETERS 248
- 4.5 CONSUMABLES 268
- 4.5.1 MASKS 272
- 4.5.1.1 Nasal Masks 276
- 4.5.1.2 Full Face Mask 278
- 4.5.1.3 Nasal Pillow Masks 280
- 4.5.1.4 Other Masks 282
- 4.5.2 TRACHEOSTOMY TUBE 284
- 4.5.3 NASAL CANNULAS 286
- 4.5.4 OTHER CONSUMABLES 288
- 4.5.1 MASKS 272
5 RESPIRATORY CARE DEVICES MARKET, BY APPLICATION 291
- 5.1 INTRODUCTION 291
- 5.2 OBSTRUCTIVE RESPIRATORY CONDITION 295
- 5.2.1 ASTHMA 299
- 5.2.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 302
- 5.2.2.1 Chronic Bronchitis 307
- 5.2.2.2 Emphysema 309
- 5.2.3 CYSTIC FIBROSIS 311
- 5.2.4 OBSTRUCTIVE SLEEP APNEA (OSA) 313
- 5.3 RESTRICTIVE RESPIRATORY CONDITION 316
- 5.3.1 ARDS 320
- 5.3.2 LUNG CANCER 322
- 5.3.3 RESTRECTIVE LUNG DISEASES 324
- 5.3.4 OTHERS 326
- 5.4 VASCULAR DISEASES 327
- 5.4.1 PULMONARY FIBROSIS 331
- 5.4.2 PULMONARY HYPERTENSION (PH) 333
- 5.4.3 PULMONARY EDEMA 335
- 5.5 INFECTIOUS RESPIRATORY CONDITION 337
- 5.5.1 PNEUMONIA 341
- 5.5.2 TUBERCULOSIS 343
- 5.6 OTHERS 345
6 RESPIRATORY CARE DEVICES GLOBAL MARKETY, BY END-USERS 348
- 6.1 INTRODUCTION 348
- 6.2 HOSPITALS 351
- 6.2.1 EMERGENCY CARE 355
- 6.2.2 CRITICAL CARE/INTENSIVE CARE UNIT (ICU) 357
- 6.2.3 ACUTE CARE 358
- 6.2.4 SLEEP CENTER UNIT 359
- 6.2.5 OTHER HOSPITAL CARE SETTINGS (OPD) 360
- 6.3 HOME HEALTH CARE 361
- 6.4 AMBULATORY SURGICAL CENTERS 363
7 REGIONAL MARKET ANALYSIS 365
- 7.1 INTRODUCTION 365
- 7.2 NORTH AMERICA 369
- 7.2.1 UNITED STATES (U.S.) 409
- 7.2.2 REST OF NORTH AMERICA 415
- 7.3 EUROPE 420
- 7.3.1 GERMANY 461
- 7.3.2 THE U.K. 466
- 7.3.3 FRANCE 471
- 7.3.4 REST OF EUROPE 474
- 7.4 ASIA-PACIFIC 480
- 7.4.1 JAPAN 521
- 7.4.2 CHINA 526
- 7.4.3 INDIA 531
- 7.4.4 REST OF APAC 537
- 7.5 REST OF THE WORLD 542
- 7.5.1 BRAZIL 583
- 7.5.2 REST OF LATIN AMERICA 587
- 7.5.3 MIDDLE EAST AND OTHER COUNTRIES 592
8 COMPANY DEVELOPMENTS 597
- 8.1 INTRODUCTION 597
- 8.2 NEW PRODUCT LAUNCHES 598
- 8.3 APPROVALS 601
- 8.4 ACQUISITIONS 603
- 8.5 AGREEMENTS 604
- 8.6 OTHERS 605
9 MAJOR COMPANIES 607
- 9.1 DRAGERWERK AG & CO. KGAA 607
- 9.1.1 OVERVIEW 607
- 9.1.2 FINANCIALS 608
- 9.1.3 PRODUCT PORTFOLIO 611
- 9.1.4 KEY DEVELOPMENTS 612
- 9.1.5 BUSINESS STRATEGY 613
- 9.1.6 SWOT ANALYSIS 614
- 9.2 FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED 615
- 9.2.1 OVERVIEW 615
- 9.2.2 FINANCIALS 616
- 9.2.3 PRODUCT PORTFOLIO 619
- 9.2.4 KEY DEVELOPMENTS 622
- 9.2.5 BUSINESS STRATEGY 623
- 9.2.6 SWOT ANALYSIS 624
- 9.3 GE HEALTHCARE 625
- 9.3.1 OVERVIEW 625
- 9.3.2 FINANCIALS 626
- 9.3.3 PRODUCT PORTFOLIO 628
- 9.3.4 KEY DEVELOPMENTS 628
- 9.3.5 BUSINESS STRATEGY 629
- 9.3.6 SWOT ANALYSIS 630
- 9.4 GETINGE GROUPS (MAQUET GMBH & CO. KG) 631
- 9.4.1 OVERVIEW 631
- 9.4.2 FINANCIALS 632
- 9.4.3 PRODUCT PORTFOLIO 635
- 9.4.4 KEY DEVELOPMENTS 635
- 9.4.5 BUSINESS STRATEGY 636
- 9.4.6 SWOT ANALYSIS 637
- 9.5 INOGEN, INC. 638
- 9.5.1 OVERVIEW 638
- 9.5.2 FINANCIALS 639
- 9.5.3 PRODUCT PORTFOLIO 640
- 9.5.4 KEY DEVELOPMENTS 640
- 9.5.5 BUSINESS STRATEGY 641
- 9.5.6 SWOT ANALYSIS 642
- 9.6 MASIMO CORPORATION 643
- 9.6.1 OVERVIEW 643
- 9.6.2 FINANCIALS 644
- 9.6.3 PRODUCT PORTFOLIO 646
- 9.6.4 KEY DEVELOPMENTS 647
- 9.6.5 BUSINESS STRATEGY 648
- 9.6.6 SWOT ANALYSIS 649
- 9.7 MEDTRONIC, PLC 650
- 9.7.1 OVERVIEW 650
- 9.7.2 FINANCIALS 651
- 9.7.3 PRODUCT PORTFOLIO 654
- 9.7.4 KEY DEVELOPMENTS 657
- 9.7.5 BUSINESS STRATEGY 657
- 9.7.6 SWOT ANALYSIS 658
- 9.8 PHILIPS N.V. 659
- 9.8.1 OVERVIEW 659
- 9.8.2 FINANCIALS 660
- 9.8.3 PRODUCT PORTFOLIO 663
- 9.8.4 KEY DEVELOPMENTS 667
- 9.8.5 BUSINESS STRATEGY 669
- 9.8.6 SWOT ANALYSIS 670
- 9.9 RESMED INC. 671
- 9.9.1 OVERVIEW 671
- 9.9.2 FINANCIALS 672
- 9.9.3 PRODUCT PORTFOLIO 674
- 9.9.4 KEY DEVELOPMENTS 676
- 9.9.5 BUSINESS STRATEGY 679
- 9.9.6 SWOT ANALYSIS 680
- 9.10 VYAIRE MEDICAL, INC 681
- 9.10.1 OVERVIEW 681
- 9.10.2 FINANCIALS 681
- 9.10.3 PRODUCT PORTFOLIO 682
- 9.10.4 KEY DEVELOPMENTS 686
- 9.10.5 BUSINESS STRATEGY 686
Summary:
Get latest Market Research Reports on Respiratory Care Devices. Industry analysis & Market Report on Respiratory Care Devices is a syndicated market report, published as Respiratory Care Devices Global Market - Forecast to 2026. It is complete Research Study and Industry Analysis of Respiratory Care Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
